Table of Contents
In India CDSCO is the national regulatory authority who is responsible for the approval and oversight of medical devices. Whether you are an Indian manufacturer or an importer, one needs to have a valid license from CDSCO for sale and distribution. Not only for sale distribution CDSCO allocates licenses for testing, clinical investigation etc, so based one the requirement one can apply for the licenses. The timeline for approval is based on various factors such as documentation, queries, data manufacturers or importers have.
The time required for CDSCO registration varies depending on several factors:Device Classification
CDSCO has classified the medical devices into four categories based on risk:
| Class | Risk Level | Examples |
| Class A | Low Risk | Surgical dressings , thermometers |
| Class B | Low – Moderate | Infusion sets, suction equipment |
| Class C | Moderate – High Risk | Orthopedic implants, cardiac catheters |
| Class D | High Risk | Pacemakers |
Kindly note that devices that falls under Higher risk (Class C & D) require more rigorous scrutiny and thus have longer approval timelines.
| Form | Purpose | Device Class | Issuing Authority | License Issued | Estimated Timeline |
| MD-3 | Manufacturing license application | Class A & B | State Licensing Authority (SLA) | MD-5 | 3–6 months |
| MD-6 | Loan license to manufacture Class A & B devices | – | SLA | – | 3–6 months |
| MD-7 | Manufacturing license application | Class C & D | Central Licensing Authority (CLA) | MD-19 | 6 -12 months |
| MD-10 | Loan license to manufacture Class C & D devices | Class C & D | CDSCO | MD-11 | 6 -12 months |
| MD-12 | Test license to manufacture for clinical investigation or evaluation | All Classes | CDSCO | MD-13 | 2–4 months |
| MD-14 | Import license application | All Classes | CDSCO | MD-15 | Up to 9 months |
| MD-16 | Test license to import for clinical investigation or evaluation | All Classes | CDSCO | MD-17 | 2–4 months |
| MD-22 | Application for permission to conduct clinical investigation | Investigational Devices | CDSCO | MD-23 | 3–6 months |
| MD-24 | Permission to import investigational medical device for clinical investigation | Investigational Devices | CDSCO | MD-25 | 3–6 months |
| MD-26 | Import license for devices without predicate | All Classes | CDSCO | MD-27 | 6–9 months |
Note: These timelines are just a very rough idea of what might be expected. The actual timelines of the whole process can be affected by many factors such as the quality of the submission, the occurrence of regulatory queries, and the requirements of the device.

1. Application Submission
Prepare an application in detail as well as the complete supporting documents.
2. Preliminary Scrutiny
CDSCO checks whether the documents submitted are complete and correct.
3. Technical Evaluation
Safety, efficacy, and performance data of the product are examined.
4. Clinical Trials (if applicable)
It is necessary that class C & D devices undergo clinical trials if they have never been approved in India.
5. Inspection & Audit
CDSCO can do a physical inspection of the manufacturing facilities to see whether the safety and standards are maintained.
6. Grant of License/Registration
After a successful inspection, CDSCO issues the registration certificate.
Tips to Expedite CDSCO Approval:
• Ensure that documentation is done thoroughly and accurately
• Provide CDSCO with your responses quickly
• Work together with regulatory experts for guidance
• Keep abreast of CDSCO guidelines and changes
The approval of CDSCO is an essential part of the process which guarantees that medical devices to be sold in the Indian market are of the required standard in terms of safety, quality, and performance. Despite that, the process can be quite exhaustive. A well-done preparation and a proactive communication can largely cut the waiting time. By filling accurate and complete documentation, supplying regulatory queries swiftly, and following the latest CDSCO guidelines, the manufacturers and the importers will be able to facilitate the authorization process. Additionally, the collaboration with the seasoned regulators enhances the effectiveness of the compliance and thus, the arrival of the innovative medical devices to the Indian healthcare market is made possible.
The Categorisation Problem Of all the challenges in India’s Cosmetic Import registration process, product categorisation is one of the most underestimated. Under the Cosmetics Rules, 2020, CDSCO..
For foreign Medical Device companies entering India, the authorized agent is not just a compliance checkpoint — it is a strategic regulatory role. The right appointment can support licensing procedu..
Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage un..
India
Global
Sales: +91 7672005050
Reception: +91-11-45214546
9 am to 6 pm (Monday to Friday)